Pediatric Interventional Cardiology Market to Reach USD 4.34 Billion by 2033, Driven by Rising Congenital Heart Disease Cases and Technological Advancements
The global pediatric interventional cardiology market is projected to grow from USD 2.42 billion in 2024 to USD 4.34 billion by 2033, registering a compound annual growth rate (CAGR) of 6.68% during 2025–2033.
This growth is primarily driven by the rising prevalence of congenital heart diseases (CHD) among children—such as ventricular septal defect (VSD), patent ductus arteriosus (PDA), atrioventricular canal defect, and atrial septal defect (ASD).
According to a Cambridge University report, nearly 15 million children in low- and middle-income countries die or become disabled each year from treatable or preventable heart diseases—underscoring the urgent need for advanced pediatric cardiac care solutions.
Market Growth Drivers
global pediatric Technological advancements in pediatric interventional cardiology devices—including balloons, guidewires, bio-absorbable stents, catheters, vascular closure devices, and atherectomy systems—are further fueling market expansion.
The rising preference for minimally invasive procedures due to reduced infection risk, faster recovery times, and minimal scarring is another key contributor.
In the United States, approximately 40,000 infants are born each year with cardiac abnormalities—around 1% of all births—with one in four requiring specialized care. Enhanced awareness, early diagnosis, and improved access to pediatric cardiac specialists are further supporting market growth.
Leading Companie
- Abbott Laboratories (U.S.) – Founded in 1888, Abbott reported $42.0 billion in 2023 revenue. The company develops cardiovascular, metabolic, neuromodulation, and structural heart solutions distributed through hospitals, pharmacies, and global distributors.
- Boston Scientific Corporation (U.S.) – Established in 1979, the company generated $16.7 billion in 2023 revenue. Boston Scientific provides interventional cardiology, electrophysiology, and vascular devices worldwide.
- Medtronic PLC (Ireland) – Founded in 1949, Medtronic posted $32.4 billion in 2023 revenue. The company designs devices for cardiovascular, neurological, and musculoskeletal conditions across global healthcare markets.
- Edwards Lifesciences Corporation (U.S.) – Founded in 1958, Edwards reported $5.4 billion in 2023 revenue. It specializes in structural heart products, surgical valve devices, and hemodynamic monitoring systems.
- Johnson & Johnson (U.S.) – Established in 1886, J&J achieved $88.8 billion in 2023 revenue. The company offers a comprehensive portfolio across pharmaceuticals and medical devices, including cardiovascular and neurovascular care.
SWOT Snapshots of Key Players
- Siemens Healthineers
- Strength: Technological leadership in imaging, diagnostics, and AI-driven healthcare.
- Opportunity: Expanding into digital health, telemedicine, and AI-based predictive diagnostics in emerging markets.
- GE HealthCare
- Strength: Presence in over 160 countries and a diversified medical technology portfolio.
- Opportunity: Growth in emerging markets through scalable and affordable digital health solutions.
- Cardinal Health Inc.
- Strength: Extensive U.S. distribution network serving over 90% of hospitals.
- Opportunity: Expansion through acquisitions, such as the $1.12 billion acquisition of Integrated Oncology Network, strengthening oncology and specialized care offerings.
- June 2025: Canid raised USD 10 million (Series A) to expand its pediatric vaccine management platform, highlighting investor confidence in pediatric health technology innovations.
- April 2025: Abbott received FDA approval for its Tendyne transcatheter mitral valve replacement system, the first device of its kind to replace mitral valves without open-heart surgery—benefiting patients with severe mitral annular calcification.
- January 2025: Boston Scientific acquired Bolt Medical for up to USD 664 million, expanding its intravascular lithotripsy capabilities for treating complex calcified artery disease in both adult and pediatric patients.
- December 2024: DPU Super Speciality Hospital in Pimpri, Pune, opened a 10-bed Pediatric Cardiac ICU equipped with advanced medical technology. The facility, supported by a CSR contribution from Bajaj Finserv, offers comprehensive cardiac care for children.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
source link: https://www.businesswire.com
